1. Home
  2. NEWT vs FHTX Comparison

NEWT vs FHTX Comparison

Compare NEWT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

N/A

Current Price

$12.32

Market Cap

400.6M

Sector

Finance

ML Signal

N/A

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

N/A

Current Price

$6.22

Market Cap

419.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEWT
FHTX
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.6M
419.9M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
NEWT
FHTX
Price
$12.32
$6.22
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$15.33
$11.50
AVG Volume (30 Days)
241.5K
299.4K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
6.00%
N/A
EPS Growth
11.22
25.32
EPS
0.90
N/A
Revenue
N/A
$30,909,000.00
Revenue This Year
N/A
$8.89
Revenue Next Year
$12.45
$20.13
P/E Ratio
$13.70
N/A
Revenue Growth
N/A
36.75
52 Week Low
$9.59
$3.27
52 Week High
$15.69
$7.61

Technical Indicators

Market Signals
Indicator
NEWT
FHTX
Relative Strength Index (RSI) 29.57 51.05
Support Level $11.41 $4.21
Resistance Level $12.38 $6.76
Average True Range (ATR) 0.32 0.53
MACD -0.07 -0.04
Stochastic Oscillator 8.19 12.95

Price Performance

Historical Comparison
NEWT
FHTX

About NEWT NewtekOne Inc.

NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: